Circumventing Pediatric Solid Tumor Microenvironment Resistance by Combinatorial CAR NK and Immunomodulating Therapy |
New York Medical College / Mitchell Cairo, MD |
Reach Grants |
2023 |
New York |
Immunoglobulin High-Throughput Sequencing for Refining Risk Stratification in Infant B-ALL |
University of Rochester / Carol Fries Simpson, MD |
Reach Grants |
2023 |
New York |
Reversing Feedback Immunosuppression during Oncolytic Virotherapy of Pediatric High Grade Glioma |
Augusta University Research Institute, Inc. / Bangxing Hong, PhD |
Reach Grants |
2023 |
Georgia |
Feasibility Study of Dual Inhibition of MDM2 and Tubulin in Treatment of AML |
Emory University / Muxiang Zhou, MD |
Reach Grants |
2023 |
Georgia |
Identification of Aberrantly Methylated Differentially Expressed Genes to Distinguish High- vs. Low-Risk Retinoblastoma |
Children’s Hospital Los Angeles / Jesse Berry, MD |
Reach Grants |
2023 |
California |
The Impact of the Intestinal Microbiome on Sarcoma Metastasis |
Albert Einstein College of Medicine / David Loeb, MD, PhD |
Innovation Grants |
2023 |
New York |
Ectopic Neuroligin Signaling in Pediatric Glioblastoma |
University of Utah / Alex Shcheglovitov, PhD |
Innovation Grants |
2023 |
Utah |
Mechanisms to Redirect Tumor Associated Macrophages to Target Retinoblastoma Cells |
The Regents of the University of Minnesota / Timothy Hallstrom, PhD |
Innovation Grants |
2023 |
Minnesota |
Development of RADARS-based Therapy to Treat Fusion Molecule Driven Pediatric Malignancies |
Boston Children’s Hospital / Alan B. Cantor, MD, PhD |
Innovation Grants |
2023 |
Massachusetts |
Stapled Oncolytic Peptides for Treatment-Resistant Pediatric Leukemias |
Dana-Farber Cancer Institute / Loren Walensky, MD, PhD |
Innovation Grants |
2023 |
Massachusetts |